新聞中心及演示文稿
上一篇文章   |   下一篇文章
創新平台, 監管信息公告 | 2009-02-17

Chi-Med Announces Completion of Patient Enrolment in its US Phase II Crohn’s Disease Clinical Trial of HMPL-004, its Lead Anti-Inflammatory Drug Candidate